The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Wednesday, March 04, 2020
AstraZeneca Pharmaceuticals
NCCN Oncology Research Program announced three research projects selected to receive funding to improve healthcare provider performance and/or ...
read more
AbbVie announced the trial of VENCLEXTA in combination with low-dose cytarabine versus LDAC in combination with placebo did not meet its primary ...
read more
Friday, February 28, 2020
Active Motif Shanghai, in collaboration with Fudan University and its affiliated Public Health Clinical Center, used its single-cell AbEpic screening ...
read more
Wednesday, February 26, 2020
CPhI Japan has announced the event will be postponed until a new date later in the year after consultation with key stakeholders and consideration of ...
read more
Wednesday, February 26, 2020
Perrigo and Catalent Pharma Solutions announced the FDA has approved Perrigo’s ANDA for generic albuterol sulfate inhalation aerosol.
read more
Tuesday, February 25, 2020
Sanofi plans to create a European company dedicated to the production and marketing to third parties of active pharmaceutical ingredients (APIs).
read more
Tuesday, February 25, 2020
Noxopharm announced the FDA has approved the IND application for Veyonda® for combination treatment with doxorubicin in patients with soft tissue ...
read more
Monday, February 24, 2020
Esperion announced the FDA approved NEXLETOL tablet, an oral, once-daily, non-statin LDL-Cholesterol (LDL-C) lowering medicine.
read more
Friday, February 21, 2020
Annovis Bio was issued a patent for a method of treating Parkinson’s disease, Lewy body dementia and other Lewy body diseases.
read more
Friday, February 21, 2020
BioMarin announced the FDA has accepted for Priority Review the BLA for its investigational AAV5 gene therapy, valoctocogene roxaparvovec, for ...
read more
Thursday, February 20, 2020
Retrotope announced the FDA Office of Orphan Products Development granted orphan drug designation for RT001 for Progressive SupraNuclear Palsy.
read more
Thursday, February 20, 2020
Compugen plans to initiate a study evaluating a triple combination of COM701 in combination with Opdivo and BMS-986207.
read more
Wednesday, February 19, 2020
The FDA plays an essential role in overseeing our Nation’s medical products as part of our vital mission to protect and promote public health, ...
read more
Wednesday, February 19, 2020
The independent DMC has reviewed the open-label data following the first 28-day treatment cycle for three patients in each of the two 15 mg/kg dosing ...
read more
Friday, February 14, 2020
Soligenix announced its RiVax development program for prevention of ricin intoxication has received "Fast Track" designation from the FDA.
read more